Cargando…
2357. Descriptive Analyses of mRNA-1273 (Moderna COVID-19 vaccine) Spontaneous Reports by Geographic Regions
BACKGROUND: Given global distribution of the mRNA-1273 vaccine in the pandemic, an understanding of regional differences in adverse event (AE) reporting is needed. METHODS: The Moderna global safety database (GSDB) contains mRNA-1273 associated AE reports directly submitted by health care providers...
Autores principales: | Emile-Backer, Magalie, Khamamkar, Vaishali, Dharia, Priyadarshani, Laurent, Samantha St, Zhou, Cindy Ke, Esposito, Daina, Martin, David, Straus, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677020/ http://dx.doi.org/10.1093/ofid/ofad500.1978 |
Ejemplares similares
-
2336. General Safety Profile of mRNA-1273 (Moderna COVID-19 Vaccine) in the Elderly Population
por: Anteyi, Kate, et al.
Publicado: (2023) -
2391. Evaluation and Adjudication of Case Reports of Myocarditis After mRNA-1273 Vaccination
por: Urdaneta, Veronica, et al.
Publicado: (2023) -
Bullous Pemphigoid Following the Moderna mRNA-1273 Vaccine
por: Desai, Amar D, et al.
Publicado: (2022) -
Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022) -
De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)